XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating Activities:    
Net income $ 387,976 $ 342,058
Adjustments to reconcile net income to net cash from operating activities:    
Credit loss expense 0 63
Deferred tax expense (benefit) (3,378) 4,672
Accretion of loan discounts (10,572) (9,879)
Securities premium amortization (discount accretion), net 76,328 90,017
Net (gain) loss on securities transactions 0 0
Depreciation and amortization 53,303 51,550
Net (gain) loss on sale/write-down of assets/foreclosed assets 109 (1,885)
Stock-based compensation 8,703 7,756
Net tax benefit from stock-based compensation 2,894 4,505
Earnings on life insurance policies (1,561) (1,901)
Net change in:    
Trading account securities 154 (421)
Lease right-of-use assets 18,151 17,566
Accrued interest receivable and other assets (63,382) (65,849)
Accrued interest payable and other liabilities 71,187 114,361
Net cash from operating activities 539,912 552,613
Investing Activities:    
Securities held-to-maturity - Purchases (878,434) 0
Securities held to maturity: Maturities, calls and principal repayments 557,901 171,969
Securities available for sale:    
Purchases (6,702,519) (4,105,085)
Sales 0 0
Maturities, calls and principal repayments 1,140,939 3,125,786
Proceeds from sale of loans 2,365 0
Net change in loans (617,981) 1,649,429
Benefits received on life insurance policies 1,332 1,944
Proceeds from sales of premises and equipment 47 7,033
Purchases of premises and equipment (55,635) (37,088)
Proceeds from sales of repossessed properties 2,585 809
Net cash from investing activities (6,549,400) 814,797
Financing Activities:    
Net change in deposits 3,864,490 4,597,006
Net change in short-term borrowings (657,785) 110,232
Proceeds from stock option exercises 11,760 37,810
Purchase of treasury stock (996) (1,342)
Cash dividends paid on preferred stock (5,006) (5,488)
Cash dividends paid on common stock (153,277) (140,510)
Net cash from financing activities 3,059,186 4,597,708
Net change in cash and cash equivalents (2,950,302) 5,965,118
Cash and cash equivalents at beginning of period 16,583,000 10,288,853
Cash and cash equivalents at end of period $ 13,632,698 $ 16,253,971